Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Department of Surgery, Queen Elizabeth Hospital, Birmingham, UK.
Ann Surg Oncol. 2018 Jun;25(6):1536-1543. doi: 10.1245/s10434-018-6393-x. Epub 2018 Feb 22.
Established practice for the management of soft tissue sarcoma (STS) of the extremity and trunk wall combines perioperative radiotherapy (RT) with limb-preserving surgery.
The aim of this study was to explore whether high-quality surgery at high-volume centers may offer equivalent local control in selected cases, when RT needs to be avoided.
All consecutive adult cases of primary, high-risk STSs treated in a high-volume reference center over a 12-year timeframe were included, and, on retrospective analysis, were divided into two groups. Group A received RT with surgery, and Group B received surgery alone. The primary endpoint was local recurrence-free survival (LRFS).
Overall, 390 patients were included (318 in Group A and 72 in Group B), with a median follow-up of 53 months. The main reasons for avoiding RT were patient choice and technical considerations (vascular bypass or flap reconstruction). No difference in R0 resection was seen between the groups (79% vs. 70%; p = 0.18), but Group A had more G3 tumors (80.5% vs. 68%; p = 0.021). No difference in 5-year LRFS was evident (84% vs. 81%; p = 0.16).
LRFS did not differ between patients with high-risk STSs receiving perioperative RT and those treated with surgery alone. The study was retrospective and omission of RT was largely uncontrolled with inherent bias. Nonetheless, data suggest that in experienced centers, the omission of RT did not diminish local disease outcome. Future studies on a selective approach to RT administration are awaited.
四肢和躯干壁软组织肉瘤(STS)的既定治疗方法是将围手术期放疗(RT)与保肢手术相结合。
本研究旨在探讨在需要避免 RT 的情况下,高容量中心的高质量手术是否可以为选定病例提供等效的局部控制。
回顾性分析了 12 年时间内在高容量参考中心治疗的原发性、高危 STS 成人连续病例,将其分为两组。A 组接受 RT 联合手术,B 组仅接受手术。主要终点是局部无复发生存率(LRFS)。
共纳入 390 例患者(A 组 318 例,B 组 72 例),中位随访时间为 53 个月。避免 RT 的主要原因是患者选择和技术考虑(血管旁路或皮瓣重建)。两组的 R0 切除率无差异(79% vs. 70%;p=0.18),但 A 组 G3 肿瘤更多(80.5% vs. 68%;p=0.021)。5 年 LRFS 无差异(84% vs. 81%;p=0.16)。
接受围手术期 RT 和单独手术治疗的高危 STS 患者的 LRFS 没有差异。该研究是回顾性的,RT 的遗漏主要是不受控制的,存在固有偏见。尽管如此,数据表明,在经验丰富的中心,RT 的遗漏并未降低局部疾病的结果。未来还需要进行关于 RT 管理的选择性方法的研究。